The Industrial Phase-Transfer Catalysis Experts

PTC Tip of the Month E-Newsletter

PTC Tip of the Month - October 2019

Use of Aliquat 336 for Palladium Co-Catalyzed PTC Reactions

By Marc Halpern, the leading expert in industrial phase-transfer catalysis.

Aliquat 336 (registered trademark of BASF) is a mixture of 4 quat salts, described at http://phasetransfer.com/WhatisAliquat336andAdogen464.pdf, of which 33% is methyl trioctyl ammonium chloride. Aliquat 336 has been reported to enhance the activity of palladium catalysts for Suzuki and other reactions, for more than 20 years.

The point of this PTC Tip of the Month is that if you are using a palladium catalyst for Suzuki coupling or other reactions, you should probably screen Aliquat 336 (after first making sure that the reaction can be done safely such as by running a DSC first to assure no uncontrollable exotherms) to determine if you can achieve advantage using this phase-transfer catalyst. Advantages may be in reaction performance such as control of molecular weight, advantageous reaction conditions, using a less expensive form of palladium (choice of ligands) or even using less of the expensive palladium catalyst.

To illustrate the use of Aliquat 336 in Pd catalyzed PTC reactions, following is a sampling of US Patents that have used the Aliquat 336-Pd combination over the past year.

US Patent 10,403,822 (Sep 2019): Synthesis of thienothiophene isoindigo-based polymer semiconductors
US Patent 10,392,395 (Aug 2019): Synthesis of 4,7-bis-(2-bromo-4-methylpyridin-6-yl)-2,1,3-benzothiadiazole
US Patent 10,364,316 (Jul 2019): Synthesis of 2,5-diphenyl p-xylene
US Patent 10,340,457 (Jul 2019): Synthesis of dithiopentalenes
US Patent 10,290,809 (May 2019): Synthesis of polymer between dithiofluorene and thiobenzimidazole and US Patent 10,059,796 (Aug 2018)
US Patent 10,276,799 (Apr 2019): Synthesis of Iridium phenyl-isoquinoline phenyl-triazole compounds
US Patent 10,273,329 (Apr 2019): Synthesis of carbazole-divinylbenzene copolymers
US Patent 10,199,577 (Feb 2019): Synthesis of triphenyl derivatives and US Patent 10,134,988 (Nov 2018)
US Patent 10,158,079 (Dec 2018): Synthesis of polymers of benzodithiophene
US Patent 10,005,886 (2018): Synthesis of dimethyl 2,2”,4,4”,6,6”-hexamethyl-p-terphenyl-3,3”-diester

If you want to achieve high-performance low-cost PTC processes with efficient utilization of constrained R&D resources, now contact Marc Halpern of PTC Organics to integrate the highly specialized expertise of PTC Organics in industrial phase-transfer catalysis with your company’s commercial goals.

About Marc Halpern

Marc Halpern

Dr. Halpern is founder and president of PTC Organics, Inc., the only company dedicated exclusively to developing low-cost high-performance green chemistry processes for the manufacture of organic chemicals using Phase Transfer Catalysis. Dr. Halpern has innovated PTC breakthroughs for pharmaceuticals, agrochemicals, petrochemicals, monomers, polymers, flavors & fragrances, dyes & pigments and solvents. Dr. Halpern has provided PTC services on-site at more than 260 industrial process R&D departments in 37 countries and has helped chemical companies save > $200 million. Dr. Halpern co-authored five books including the best-selling “Phase-Transfer Catalysis: Fundamentals, Applications and Industrial Perspectives” and has presented the 2-day course “Practical Phase-Transfer Catalysis” at 50 locations in the US, Europe and Asia.

Dr. Halpern founded the journal “Industrial Phase-Transfer Catalysis” and “The PTC Tip of the Month” enjoyed by 2,100 qualified subscribers, now beyond 130 issues. In 2014, Dr. Halpern is celebrating his 30th year in the chemical industry, including serving as a process chemist at Dow Chemical, a supervisor of process chemistry at ICI, Director of R&D at Sybron Chemicals and founder and president of PTC Organics Inc. (15 years) and PTC Communications Inc. (20 years). Dr. Halpern also co-founded PTC Interface Inc. in 1989 and PTC Value Recovery Inc. in 1999. His academic breakthroughs include the PTC pKa Guidelines, the q-value for quat accessibility and he has achieved industrial PTC breakthroughs for a dozen strong base reactions as well as esterifications, transesterifications, epoxidations and chloromethylations plus contributed to more than 100 other industrial PTC process development projects.

Dr. Halpern has dedicated his adult life to his family and to phase-transfer catalysis (in that order!).

Leave a Reply

Your email address will not be published. Required fields are marked *

PTC Course - In-House

Learn to choose
PTC process conditions
LIKE AN EXPERT!

Learn More